Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Alan Alda is not only a beloved actor, producer, writer and activist, but also a skilled science communicator. Those aiming to talk effectively to the public about biotech research would do well to follow his lead.
Two small companies developing therapeutic vaccines against hypertension are blazing a trail for immune treatments that address diseases of lifestyle with massive markets. But doubts linger over the safety of eliciting an immune response to normal body constituents. Jill U. Adams investigates.
Cox and Mann describe MaxQuant, a suite of algorithms for the analysis of high-resolution mass spectrometry data. The approach achieves substantial improvements in the accuracy of mass measurements and the peptide identification rate.